1
Total investments
1
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Aug 2021
Centenara Labs is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer.
Experience · 3 entries
All (3)
Investments (1)
Board (1)
2021
Board Observer
Aug 2021
Centenara Labs is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer.
Senior Counsel - Tech Startup Incubation and Scaling, Venture & Private Equity Investments
Feb 2021
Apeiron Investment Group is a discretionary investment firm founded and owned by serial entrepreneur and investor Christian Angermayer. At our core, we are driven by a bold optimism for a future where technology empowers people to live longer, healthier, and more fulfilling lives. As entrepreneurs at heart, we pride ourselves on being hands-on, reliable, and long-term partners—committed to supporting exceptional founders of companies as well as emerging asset managers in pushing the boundaries of imagination and shaping the future we aspire to live in.
We apply a global multi-strategy investment approach, with a primary focus on the US, and teams across New York, London, Berlin, Abu Dhabi, and Malta. Our efforts span direct investments in innovative companies, as well as anchor LP investments combined with minority GP stakes in emerging asset managers. Asset managers we have stakes in currently manage approximately $5 billion in external capital.
Follow Christian and Apeiron on X: @C_Angermayer and @ApeironInvests.
For media, event and podcast queries please email media@apeiron-investments.com.
2011
Senior Associate, Equity & Debt Financing, M&A, Structured Finance and Derivatives
Sep 2011
On May 1, 2024, Allen & Overy and Shearman & Sterling merged to become A&O Shearman. Follow us for more information @A&OShearman
Content on this page is general information only and not advice https://www.aoshearman.com/en/legal-notices